When should pars plana vitrectomy be performed in a monocular patient with endophthalmitis after receiving intravitreal vancomycin and ceftazidime?

When to Consider Vitrectomy in a Monocular Patient with Endophthalmitis After Intravitreal Antibiotics

In a monocular patient with endophthalmitis who has received intravitreal vancomycin and ceftazidime, pars plana vitrectomy should be performed immediately if initial visual acuity is light perception only, or within 24 hours if there is no clinical improvement after the initial antibiotic injection.

Risk Stratification Based on Initial Visual Acuity

The most critical factor determining the need for vitrectomy is the presenting visual acuity:

Light Perception Only Vision

Immediate vitrectomy is strongly indicated. The landmark Endophthalmitis Vitrectomy Study demonstrated that patients with light perception-only vision who underwent immediate vitrectomy had:

• Threefold increase in achieving ≥20/40 vision (33% vs 11%)
• Twofold increase in achieving ≥20/100 vision (56% vs 30%)
• 50% reduction in severe visual loss (20% vs 47%)

These differences were statistically significant (P < 0.001) across the entire visual acuity range 1.

Hand Motions or Better Vision

For patients presenting with hand motions or better vision, the EVS found no significant difference between immediate vitrectomy and tap-and-inject approaches 1. However, this applies to binocular patients in standard-risk scenarios.

Special Considerations for Monocular Patients

The monocular status fundamentally changes the risk-benefit calculation. While not explicitly addressed in the EVS, the stakes are dramatically higher when dealing with an only-seeing eye:

• Lower threshold for intervention: Even with hand motions vision, consider early vitrectomy (within 24 hours) rather than observation
• Zero tolerance for treatment failure: Any lack of clinical improvement within 24 hours should prompt immediate surgical intervention
• Maximize diagnostic yield: Vitrectomy provides superior microbiological samples compared to tap alone

Recent evidence supports more aggressive early vitrectomy approaches. A 2020 retrospective study found that patients receiving initial pars plana vitrectomy required significantly fewer additional treatments compared to those receiving intravitreal antibiotics alone (42% vs 85%, p < 0.0001) 2. A 2021 study demonstrated that immediate vitrectomy (within 6 hours) resulted in clinically meaningful visual improvement in 79% of cases 3.

Clinical Decision Algorithm

Proceed to immediate vitrectomy if ANY of the following:

1. Initial visual acuity is light perception only (strong evidence) 1
2. Severe vitritis obscuring retinal view (prevents assessment of retinal status)
3. No improvement or worsening at 24 hours post-antibiotics (high failure rate with antibiotics alone) 2
4. Presence of retinal involvement or hemorrhage (suggests more virulent organism)
5. Hypopyon with significant anterior chamber reaction (marker of severe infection)

Consider early vitrectomy (within 24-48 hours) if:

• Initial vision is hand motions with moderate-to-severe vitritis
• Post-injection endophthalmitis (these cases may progress rapidly) 3, 4
• Any clinical uncertainty in a monocular patient (err on side of intervention)

Surgical Approach

When performing vitrectomy for endophthalmitis in a monocular patient:

• Complete core and peripheral vitrectomy to remove infectious burden 5
• Obtain undiluted vitreous sample before infusion for culture and PCR (PCR significantly increases diagnostic yield) 6
• Inject intravitreal antibiotics at conclusion (vancomycin 1mg/0.1mL + ceftazidime 2.25mg/0.1mL)
• Consider silicone oil tamponade if severe inflammation or concern for retinal detachment 4

Critical Pitfalls to Avoid

Do not delay vitrectomy waiting for culture results. Microbiological confirmation is helpful but should never delay surgical intervention in a monocular patient with poor presenting vision or lack of clinical response.

Do not rely solely on systemic antibiotics. The EVS definitively showed no benefit from IV ceftazidime and amikacin 1. Systemic antibiotics do not achieve adequate intraocular concentrations and add unnecessary toxicity risk.

Do not adopt a "wait and see" approach in monocular patients. The standard EVS criteria (observation acceptable for hand motions or better) were derived from binocular patients. The irreversible nature of vision loss in an only eye demands more aggressive intervention.

Do not perform multiple rounds of tap-and-inject before considering vitrectomy. Each delay allows progressive retinal damage. If the first intravitreal antibiotic injection fails to show improvement within 24 hours, proceed directly to vitrectomy rather than repeating injections 2.

The combination of monocular status and endophthalmitis creates a surgical emergency where the threshold for vitrectomy must be substantially lower than in binocular patients, with light perception vision being an absolute indication and any lack of improvement within 24 hours warranting immediate surgical intervention.